BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 38031155)

  • 21. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark.
    von Huth S; Lillevang ST; Røge BT; Madsen JS; Mogensen CB; Coia JE; Möller S; Justesen US; Johansen IS
    Int J Infect Dis; 2021 Nov; 112():96-102. PubMed ID: 34534698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.
    Hodgson D; Colton H; Hornsby H; Brown R; Mckenzie J; Bradley KL; James C; Lindsey BB; Birch S; Marsh L; Wood S; Bayley M; Dickson G; James DC; Nicklin MJH; Sayers JR; Zafred D; Rowland-Jones SL; Kudesia G; Kucharski A; ; Darton TC; de Silva TI; Collini PJ
    medRxiv; 2021 Jul; ():. PubMed ID: 34268521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
    Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
    J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
    PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.
    Brousseau N; Morin L; Ouakki M; Savard P; Quach C; Longtin Y; Cheng MP; Carignan A; Dufresne SF; Leduc JM; Lavallée C; Gauthier N; Bestman-Smith J; Arrieta MJ; Ishak M; Lévesque S; Martin P; De Serres G
    CMAJ; 2021 Dec; 193(49):E1868-E1877. PubMed ID: 34903591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France.
    Garlantezec R; Tadié E; Heslan C; Gary-Bobo P; Oumari S; Saade A; Sitruk A; Tattevin P; Thibault V; Paris C;
    Infect Dis Now; 2022 Nov; 52(8):447-452. PubMed ID: 36108975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff.
    Bahrs C; Kimmig A; Weis S; Ankert J; Hagel S; Maschmann J; Stallmach A; Steiner A; Bauer M; Behringer W; Baier M; Kesselmeier M; Richert C; Zepf F; Walter M; Scherag A; Kiehntopf M; Löffler B; Pletz MW
    Transbound Emerg Dis; 2022 Mar; 69(2):720-730. PubMed ID: 33605549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital.
    Airoldi C; Patrucco F; Milano F; Alessi D; Sarro A; Rossi MA; Cena T; Borrè S; Faggiano F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    Martin CA; Pan D; Melbourne C; Teece L; Aujayeb A; Baggaley RF; Bryant L; Carr S; Gregary B; Gupta A; Guyatt AL; John C; McManus IC; Nazareth J; Nellums LB; Reza R; Simpson S; Tobin MD; Woolf K; Zingwe S; Khunti K; Abrams KR; Gray LJ; Pareek M;
    PLoS Med; 2022 May; 19(5):e1004015. PubMed ID: 35617423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care.
    Klevebro S; Bahram F; Elfström KM; Hellberg U; Hober S; Merid SK; Kull I; Nilsson P; Tornvall P; Wang G; Conneryd Lundgren K; Ponzer S; Dillner J; Melén E
    Scand J Public Health; 2021 Nov; 49(7):707-712. PubMed ID: 34148454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study.
    Albrecht S; Grässli F; Cusini A; Brucher A; Goppel S; Betschon E; Möller JC; Ortner M; Ruetti M; Stocker R; Vuichard-Gysin D; Besold U; Risch L; Von Kietzell M; Schlegel M; Vernazza P; Kuster SP; Kahlert CR; Kohler P
    Swiss Med Wkly; 2024 Apr; 154():3734. PubMed ID: 38689545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.
    Taher WT; Bawazir AA; Sallam TA; Alsurimi K
    BMC Infect Dis; 2023 Nov; 23(1):761. PubMed ID: 37932664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali.
    Somboro AM; Cissoko Y; Camara I; Kodio O; Tolofoudie M; Dembele E; Togo ACG; Ba DM; Sarro YDS; Baya B; Samake S; Diallo IB; Kumar A; Traore M; Kone B; Kone A; Diarra B; Dabitao DK; Wague M; Dabo G; Doumbia S; Holl JL; Murphy RL; Diallo S; Maiga AI; Maiga M; Dao S
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
    Meylan S; Dafni U; Lamoth F; Tsourti Z; Lobritz MA; Regina J; Bressin P; Senn L; Grandbastien B; Andre C; Fenwick C; D'Acremont V; Croxatto A; Guilleret I; Greub G; Manuel O; Calandra T; Pantaleo G; Lazor-Blanchet C;
    BMJ Open; 2021 Jul; 11(7):e049232. PubMed ID: 34226231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 seroprevalence in high-risk health care workers in a Belgian general hospital: evolution from the first wave to the second.
    Wauthier L; Delefortrie Q; Eppe N; Vankerkhoven P; Wolff E; Dekeyser M; Cirriez JM; Grimmelprez A
    Acta Clin Belg; 2022 Dec; 77(6):906-914. PubMed ID: 34789077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 seroprevalence in healthcare workers and risk factors.
    Weber S; Didelot A; Agrinier N; Peyrin-Biroulet L; Schvoerer E; Rabaud C; Jeulin H
    Infect Dis Health; 2022 Nov; 27(4):203-210. PubMed ID: 35644801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: A multicenter seroprevalence study.
    Al-Maani A; Al Wahaibi A; Al-Sooti J; Al Abri B; Al Shukri I; AlRisi E; Al Abri L; AlDaghari K; Al Subhi M; AlMaqbali S; AlBurtamani S; AlAbri A; Al Salami A; Al-Beloushi I; Al-Zadjali N; Alqayoudhi A; Al-Kindi H; Al Shaqsi K; Al-Jardani A; Al-Abri S
    Int J Infect Dis; 2021 Jun; 107():257-263. PubMed ID: 33930541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
    Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
    Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.